Search Results - Bergh, J.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study

    First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study by Bergh, J., Bondarenko, I., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N., Makhson, A., Cortes, J., Lortholary, A., Bischoff, J., Chan, Arlene, Delaloge, S., Huang, X., Kern, K., Giorgetti, C.

    Published 2012
    Get full text
  2. 2
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... by Baselga, J., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S., Melichar, B., Chan, Arlene, Mángel, L., Bergh, J., Costa, F., Gómez, H., Gradishar, W., Hudis, C., Rapoport, B., Roché, H., Patricia, M., Huang, L., Meinhardt, G., Zhang, J., Schwartzberg, L.

    Published 2017
    Get full text

Search Tools: